Evidence map›Paper›PMID 22111719›Full record

ArticleThe New England journal of medicine2011

Emergency hospitalizations for adverse drug events in older Americans.

Daniel S Budnitz, Maribeth C Lovegrove, Nadine Shehab, Chesley L Richards

4 registry-linked trialsOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 681 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
681citing papers in PubMed, 6 pooled it
69.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02624908 phase4unknown statusstarted 2016, after this paper: background citation

Canagliflozin-Mealtime Insulin Rescue

Ran2016Enrolled40Registered outcomes5Posted comparisons0ConditionsDiabetes Mellitus, Type 2ArmsCanagliflozin, Placebo
Open the trial in the graph
NCT01970709 unknown statusnot on this mapstarted 2013, after this paper: background citation

DART Registry: Diagnosing Adverse Drug Reactions Registry

Typeobservational_patient_registrySponsorRenaissance RXRan2013Enrolled250,000ConditionsGenetics of Drug Metabolism
NCT04357288 nacompletednot on this mapstarted 2020, after this paper: background citation

Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation

TypeinterventionalSponsorUniversity of UtahRan2020 to 2024Enrolled1,117ConditionsAtrial FibrillationArmsPatient Decision Aid, Encounter Decision Aid
NCT06652867 completednot on this mapstarted 2024, after this paper: background citation

Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event

TypeobservationalSponsorRoyal College of Surgeons in Ireland - Medical University of BahrainRan2024 to 2024Enrolled150ConditionsHypoglycemia
3 · Its place in the literature

Who cites it

681 citing papers in PubMed, 6 syntheses or guidelines pooled it, 1,802 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Article

621 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Daniel S BudnitzDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. dbudnitz@cdc.gov
Maribeth C Lovegrove
Nadine Shehab
Chesley L Richards
Centers for Disease Control and Prevention · UGCenters for Disease Control and Prevention · USEmory University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdverse drug events are important preventable causes of hospitalization in older adults. However, nationally representative data on adverse drug events that result in hospitalization in this population have been limited.

methodsWe used adverse-event data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project (2007 through 2009) to estimate the frequency and rates of hospitalization after emergency department visits for adverse drug events in older adults and to assess the contribution of specific medications, including those identified as high-risk or potentially inappropriate by national quality measures.

resultsOn the basis of 5077 cases identified in our sample, there were an estimated 99,628 emergency hospitalizations (95% confidence interval [CI], 55,531 to 143,724) for adverse drug events in U.S. adults 65 years of age or older each year from 2007 through 2009. Nearly half of these hospitalizations were among adults 80 years of age or older (48.1%; 95% CI, 44.6 to 51.6). Nearly two thirds of hospitalizations were due to unintentional overdoses (65.7%; 95% CI, 60.1 to 71.3). Four medications or medication classes were implicated alone or in combination in 67.0% (95% CI, 60.0 to 74.1) of hospitalizations: warfarin (33.3%), insulins (13.9%), oral antiplatelet agents (13.3%), and oral hypoglycemic agents (10.7%). High-risk medications were implicated in only 1.2% (95% CI, 0.7 to 1.7) of hospitalizations.

conclusionsMost emergency hospitalizations for recognized adverse drug events in older adults resulted from a few commonly used medications, and relatively few resulted from medications typically designated as high-risk or inappropriate. Improved management of antithrombotic and antidiabetic drugs has the potential to reduce hospitalizations for adverse drug events in older adults.

Indexed as

AgedAged, 80 and overAge DistributionDrug OverdoseDrug-Related Side Effects and Adverse ReactionsEmergenciesEmergency Service, HospitalFemaleFibrinolytic AgentsHospitalizationHumansHypoglycemic AgentsMalePopulation SurveillanceUnited StatesFibrinolytic AgentsHypoglycemic Agents

Identifiers

PMID22111719
OpenAlexW2096721022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.